These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 6327321)

  • 1. Human lymphoblastoid cell line producing protective monoclonal IgG1, kappa anti-tetanus toxin.
    Tiebout RF; Stricker EA; Hagenaars R; Zeijlemaker WP
    Eur J Immunol; 1984 May; 14(5):399-404. PubMed ID: 6327321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of stable Epstein-Barr (EB) virus transformed cell lines and mouse-human hybridomas producing a large quantity of anti-tetanus toxoid (TT) monoclonal antibody.
    Minakawa H; Hirata Y; Sugawara I; Fukuda A; Yoshida TO
    Behring Inst Mitt; 1985 Dec; (78):139-47. PubMed ID: 3008706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renewal of EBV-hybridoma method: efficient generation of recombinant fully human neutralizing IgG antibodies specific for tetanus toxin by use of tetroma cells.
    Ainai A; Kawase T; Ida A; Maeda Y; Ohba H; Ikeda Y; Sato H; Takahashi M; Chiba J
    Hum Antibodies; 2006; 15(4):139-54. PubMed ID: 17522436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Construction of human monoclonal antibodies against rabies NS-protein antigen by Epstein-Barr virus transformation.
    Gebauer W; Lindl T
    Arzneimittelforschung; 1990 Jun; 40(6):718-22. PubMed ID: 2168706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Establishment of specific antibody producing human lines by antigen preselection and Epstein-Barr virus (EBV)-transformation.
    Steinitz M; Koskimies S; Klein G; Mäkelä O
    J Clin Lab Immunol; 1979 Apr; 2(1):1-7. PubMed ID: 95800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human monoclonal antibody to purified protein derivative of tuberculin produced by hybrids constructed with Epstein-Barr virus-transformed B lymphocytes and mouse myeloma cells.
    Garzelli C; Puglisi C; Falcone G
    Eur J Immunol; 1986 May; 16(5):584-7. PubMed ID: 3009205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human monoclonal antibodies to a genus-specific chlamydial antigen, produced by EBV-transformed B cells.
    Rosén A; Persson K; Klein G
    J Immunol; 1983 Jun; 130(6):2899-902. PubMed ID: 6189902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A human hybrid hybridoma.
    Tiebout RF; van Boxtel-Oosterhof F; Stricker EA; Zeijlemaker WP
    J Immunol; 1987 Nov; 139(10):3402-5. PubMed ID: 3119707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Production of anti-tumor human monoclonal antibodies using different approaches.
    Liu H; Xu ZL; Wang Y; Yang L; Feng O; Li Y; Wang YM; Zhang GG
    Hum Antibodies Hybridomas; 1993 Jan; 4(1):2-8. PubMed ID: 8381684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of antibody production by an antigen-specific EBV-transformed B-lymphoblastoid cell line: effect of high-dose antigen and antigen-pulsed T cells.
    McCaughan GW; Brown MH; Callard RE
    Immunology; 1986 Aug; 58(4):597-602. PubMed ID: 3015782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A human hybrid myeloma for production of human monoclonal antibodies.
    Kozbor D; Tripputi P; Roder JC; Croce CM
    J Immunol; 1984 Dec; 133(6):3001-5. PubMed ID: 6092464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimisation of human anti-tetanus toxoid antibody responses and location of human cells in SCID mice transplanted with human peripheral blood leucocytes.
    Jackson DJ; Kumpel BM
    Hum Antibodies; 1997; 8(4):181-8. PubMed ID: 9395920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of antigen uptake and presentation by Epstein-Barr virus-transformed human lymphoblastoid B cells.
    Chu E; Umetsu D; Lareau M; Schneeberger E; Geha RS
    Eur J Immunol; 1984 Apr; 14(4):291-8. PubMed ID: 6327319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro generated human monoclonal trinitrophenyl-specific B cell lines. Evidence that human and murine anti-trinitrophenyl monoclonal antibodies cross-react with Escherichia coli beta-galactosidase.
    Golding B; Inghirami G; Peters E; Hoffman T; Balow JE; Tsokos GC
    J Immunol; 1987 Dec; 139(12):4061-6. PubMed ID: 2826579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The hybridization of EBV-immortalized human B-lymphocytes with a human-mouse heteromyeloma cell line.
    Jahn S; Walper A; Grunow R; Heym S; Volk HD; von Baehr R
    Allerg Immunol (Leipz); 1990; 36(4):359-65. PubMed ID: 1965878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of antibody-producing cell lines by Epstein-Barr virus.
    Viallat JR; Kourilsky FM
    Pathol Biol (Paris); 1982 Apr; 30(4):232-42. PubMed ID: 6283460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antigen-specific and polyclonal immunoglobulin production induced by a cloned tetanus toxoid-specific T cell line.
    Friedman SM; Principato MA; Thompson GS; Teichman F
    J Immunol; 1983 Mar; 130(3):1164-70. PubMed ID: 6185573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunoglobulin expression by human B lymphocytes clonally transformed by Epstein Barr virus.
    Brown NA; Miller G
    J Immunol; 1982 Jan; 128(1):24-9. PubMed ID: 6274955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human anti-tetanus toxoid monoclonal antibody secreted by EBV-transformed human B cells fused with murine myeloma.
    Kozbor D; Roder JC; Chang TH; Steplewski Z; Koprowski H
    Hybridoma; 1982; 1(3):323-8. PubMed ID: 6092264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monoclonal anti-parasite and anti-RBC antibodies produced by stable EBV-transformed B cell lines from malaria patients.
    Lundgren K; Wahlgren M; Troye-Blomberg M; Berzins K; Perlmann H; Perlmann P
    J Immunol; 1983 Oct; 131(4):2000-3. PubMed ID: 6311902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.